Company Search:
Advanced Search
Sponsored Links
Celyad Oncology - ADR Company Snapshot
Celyad Oncology operates within the Health and allied services sector. In addition to historical fundamental analyses, the complete report available to purchase compares Celyad Oncology with three other health care providers in North America: eWELLNESS HEALTHCARE Corp (2019 sales of $3,635.00 ), Spine Injury Solutions Inc ($209,373.00 ), and Creative Medical Technology Holdings Inc ($165,500.00 ).

Sales Analysis. Sales fell dramatically in 2019: During the year ended December of 2019, sales at Celyad Oncology were $6,706.50 . This is a sharp decrease of 99.8% versus 2018, when the company's sales were $3.67 million.
  Stock Performance Chart for Celyad Oncology - ADR
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 8.20
(Figures in U.S. Dollars)
1 Week -12.8%   13 Weeks -16.0%  
4 Weeks -22.1%   52 Weeks -13.3%  
Celyad Oncology - ADR Key Data:
  Ticker: CYAD Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Health & Allied Services
  2019 Sales 6,707
(Year Ending Jan 2020).
Employees: 107
  Currency: U.S. Dollars Market Cap: 114,327,221
  Fiscal Yr Ends: December Shares Outstanding: 13,942,344
  Share Type: Ordinary Closely Held Shares: 2,295,701
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.